Delivery Order SPE2DB22D3301-SPE2DB24FZ0DY
Award Date
7/9/24
Potential Completion Date
7/10/24
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,565,153,938 units of Vyvanse 40 mg capsules to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, on a firm fixed-price basis with a ceiling value of $6,580.88. The contract has a period of performance through July 16, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery...
This federal contract award is for the delivery of 4,564,881,676 units of the prescription drug Vyvanse 30 mg capsules to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The contract was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for a ceiling value of $16,404.28. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of June 12,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of 4,564,983,462 units of the prescription drug Vyvanse 30 mg capsules. The contract, with a ceiling value of $2,163.92, was awarded on June 24, 2024 by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), and has an ultimate completion date of June 25, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and does...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,359,320 units of Vyvanse 50 mg capsules. The contract has a ceiling value of $4,006.50 and is a firm-fixed price delivery order, with a period of performance through November 7, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of 4,565,115,883 units of the prescription medication Vyvanse 50 mg capsules to the Defense Logistics Agency (DLA), a major Defense agency. The $2,578.98 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a large pharmaceutical distribution company, without any set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,566,179,118 units of the prescription drug Vyvanse 30 mg capsules. The $1,150.57 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, which is a defense agency, and has an ultimate completion date of October 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,930,073 units of the prescription medication Vyvanse 40 mg capsules. The contract has a ceiling value of $1,313.24 and a completion date of June 18, 2024. It was awarded by the Defense Logistics Agency (DLA) on June 17, 2024 as a firm fixed-price delivery order contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,978,188 units of Vyvanse 40 mg capsules. The $1,567.08 contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a Defense agency, and has a completion date of June 24, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,068,663 units of the pharmaceutical product Vyvanse 60 mg capsules. The $4,187.79 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract has an ultimate completion date of July 5, 2024, and was awarded on July 3, 2024 without any set-aside designation. Amerisourcebergen, a major...
This federal contract award is for the supply of 4,564,604 units of the prescription medication Vyvanse 30mg capsules to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The $2,097.86 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies globally. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...